Monopoly Rights for High-Demand Hyrozide 25 Tablet

Dominate the Primary Hypertension & Edema Market

Hyrozide 25 Edge: The Trusted First-Line Diuretic

Seamless Combination Partner for High-Value Cardiac Drugs

Low-Risk Investment, Guaranteed Stock & Attractive Margins
Launch Your Lucrative Cardio-Diabetic PCD Business Now!

Home/Products /hydrochlorothiazide-25mg-tablet

Hyrozide 25 Tablet

Composition : Hydrochlorothiazide (25mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Hyrozide 25 Tablet (Hydrochlorothiazide 25 mg) is a cornerstone product in the essential anti-hypertensive portfolio, offering stable, perpetual demand and high prescription turnover in the Cardio-Diabetic segment.

This tablet is indispensable for its mechanism of action:

  • Thiazide Diuretic: It inhibits the sodium chloride cotransporter in the distal convoluted tubules of the kidney, leading to increased excretion of sodium, chloride, and water.

  • Dual Benefit: This action results in a reduction of extracellular fluid volume (treating edema) and a sustained decrease in peripheral vascular resistance (treating hypertension).

Why Hyrozide 25 is Your Stable & Profitable Franchise Product:

  • Essential Medicine Status: Included in all major hypertension guidelines as a first-line agent, guaranteeing long-term, high-volume prescription flow from general practitioners and specialists.

  • Synergistic Use: It is commonly co-prescribed in combination with ARBs/ACE Inhibitors (e.g., Losartan, Telmisartan) to achieve optimal blood pressure control, making it a continuous and necessary part of multiple high-value combinations.

  • Chronic Condition Demand: Hypertension and associated edema are chronic conditions requiring life-long medication, ensuring a guaranteed repeat customer base and predictable sales cycle.

Secure your exclusive Hyrozide 25 (Hydrochlorothiazide 25mg) territory now! 

Read More

About the Product

Hyrozide 25 Tablet (Hydrochlorothiazide 25 mg) is a cornerstone product in the essential anti-hypertensive portfolio, offering stable, perpetual demand and high prescription turnover in the Cardio-Diabetic segment.

This tablet is indispensable for its mechanism of action:

  • Thiazide Diuretic: It inhibits the sodium chloride cotransporter in the distal convoluted tubules of the kidney, leading to increased excretion of sodium, chloride, and water.

  • Dual Benefit: This action results in a reduction of extracellular fluid volume (treating edema) and a sustained decrease in peripheral vascular resistance (treating hypertension).

Why Hyrozide 25 is Your Stable & Profitable Franchise Product:

  • Essential Medicine Status: Included in all major hypertension guidelines as a first-line agent, guaranteeing long-term, high-volume prescription flow from general practitioners and specialists.

  • Synergistic Use: It is commonly co-prescribed in combination with ARBs/ACE Inhibitors (e.g., Losartan, Telmisartan) to achieve optimal blood pressure control, making it a continuous and necessary part of multiple high-value combinations.

  • Chronic Condition Demand: Hypertension and associated edema are chronic conditions requiring life-long medication, ensuring a guaranteed repeat customer base and predictable sales cycle.

Secure your exclusive Hyrozide 25 (Hydrochlorothiazide 25mg) territory now! 

Some patients may experience increased urination, electrolyte imbalance, dizziness, headache, or mild gastrointestinal discomfort. Rarely, severe dehydration, low potassium levels, or allergic reactions may occur and require immediate medical attention.

Hyrozide 25 Tablet is indicated for the treatment of hypertension and edema caused by conditions such as heart failure, liver cirrhosis, or kidney disorders. It helps lower high blood pressure, reduce fluid accumulation, and relieve swelling in the body, thereby improving overall cardiovascular and renal health.

This medicine should be taken under medical supervision. Patients with kidney or liver disorders, gout, diabetes, or electrolyte imbalances should consult their doctor before use. Regular monitoring of blood pressure and electrolyte levels is recommended during treatment.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation